Annuncio pubblicitario
Italia markets close in 8 hours 1 minute

  • FTSE MIB

    33.813,50
    +184,29 (+0,55%)
     

  • Dow Jones

    38.675,68
    +449,98 (+1,18%)
     

  • Nasdaq

    16.156,33
    +315,33 (+1,99%)
     

  • Nikkei 225

    38.236,07
    -38,03 (-0,10%)
     

  • Petrolio

    78,68
    +0,57 (+0,73%)
     

  • Bitcoin EUR

    59.684,96
    +548,33 (+0,93%)
     

  • CMC Crypto 200

    1.370,14
    +57,52 (+4,38%)
     

  • Oro

    2.322,30
    +13,70 (+0,59%)
     

  • EUR/USD

    1,0771
    +0,0005 (+0,04%)
     

  • S&P 500

    5.127,79
    +63,59 (+1,26%)
     

  • HANG SENG

    18.561,24
    +85,32 (+0,46%)
     

  • Euro Stoxx 50

    4.932,95
    +11,47 (+0,23%)
     

  • EUR/GBP

    0,8566
    -0,0012 (-0,14%)
     

  • EUR/CHF

    0,9748
    +0,0013 (+0,14%)
     

  • EUR/CAD

    1,4723
    -0,0001 (-0,01%)
     

Clover Health to Present at Maxim Group Emerging Growth in A.I. Virtual Conference on September 26, 2023

Clover Health Investments, Corp.
·1 minuto per la lettura
Clover Health Investments, Corp.
Clover Health Investments, Corp.

FRANKLIN, Tenn., Sept. 22, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving health equity for seniors, today announced that its CEO, Andrew Toy, will participate in a fireside chat during the Maxim Group Emerging Growth in A.I. Virtual Conference on Tuesday, September 26, 2023, at 5:00 p.m. Eastern Time.

To register and attend the conference click here.

About Clover Health:
Clover Health (Nasdaq: CLOV) is a physician enablement company committed to bringing access to great healthcare to everyone on Medicare. This includes a health equity-based focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. We operate two distinct lines of business: Insurance and Non-Insurance. Through our Insurance line of business, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. Our Non-Insurance line of business similarly aims to reduce cost-of-care while enhancing the quality of care for patients enrolled in Original Medicare.

Press Contact:
Andrew Still-Baxter
press@cloverhealth.com

Investor Relations Contact:
Ryan Schmidt
investors@cloverhealth.com